Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Virus

31.03.2021

Viruses adaptation to the tissues they infect

03.03.2021

Identified a specific region of SARS-CoV-2 useful for the diagnosis of COVID-19 and vaccine development

Pulmobiotics is a CRG spin-off that aims to develop therapeutic applications for lung diseases. Photo by Robina Weermeijer on Unsplash.
27.07.2020

Pulmobiotics: transforming a pathogen to fight lung disease

Ivermectin was recently shown to inhibit the replication of SARS-CoV-2 in vitro at very high doses, but this effect has not yet been studied in vivo. The new study will investigate this question in a randomised trial. | Picture by ISGlobal.
21.05.2020

New study to assess the efficacy of ivermectin against COVID-19

Untrained staff performing the test will get an unequivocal result from the instrument. | Picture by the UPF.
15.05.2020

InstaCOVID19: UPF develops rapid diagnostic tests for SARS-CoV-2

So far, two recent studies suggest that hydroxychloroquine may be effective in reducing the viral load of SARS-CoV-2, although the results are inconclusive and further research is needed.
13.05.2020

New study to assess the efficacy of hydroxychloroquine in the prevention and treatment of COVID-19 during pregnancy

The latest book by physicist Ricard Solé, a researcher at the IBE, takes us into the world of viruses.
11.05.2020

Viruses: complex adaptive systems

Patients who received redemsivir had a 31% faster recovery time than those who received placebo. There was a 4-day reduction in hospital stay. | Picture by Francisco Avia.
08.05.2020

The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients

The developed tool, which is at the implementation phase, uses Artificial Intelligence technology to assist the diagnosis of COVID-19. | Picture by Geralt from Pixabay.
07.05.2020

Artificial Intelligence, a great ally in the diagnosis of COVID-19

| Edited picture from the National Cancer Institute on Unsplash.
07.04.2020

On Covid-19 research at the PRBB

07.04.2020

Making a contribution to Hospital del Mar to fight against the new coronavirus pandemic

A new study explains the evolution of virus-plant interactions in Mediterranean ecosystems by considering environmental fluctuations in each case. | Picture by Dengrz from Unsplash.
16.03.2020

Researchers model the role of the environment on the spread of viral infections in plants

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2025 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org